Cerus (CERS) Competitors $1.79 +0.12 (+7.19%) (As of 11/22/2024 ET) Add Compare Share Share Competitors Stock AnalysisAnalyst ForecastsChartCompetitorsEarningsFinancialsHeadlinesInsider TradesOptions ChainOwnershipSEC FilingsShort InterestTrends CERS vs. OSUR, ANIK, LUNG, TCMD, UTMD, INO, KIDS, WST, COO, and ALGNShould you be buying Cerus stock or one of its competitors? The main competitors of Cerus include OraSure Technologies (OSUR), Anika Therapeutics (ANIK), Pulmonx (LUNG), Tactile Systems Technology (TCMD), Utah Medical Products (UTMD), Inovio Pharmaceuticals (INO), OrthoPediatrics (KIDS), West Pharmaceutical Services (WST), Cooper Companies (COO), and Align Technology (ALGN). These companies are all part of the "medical" sector. Cerus vs. OraSure Technologies Anika Therapeutics Pulmonx Tactile Systems Technology Utah Medical Products Inovio Pharmaceuticals OrthoPediatrics West Pharmaceutical Services Cooper Companies Align Technology OraSure Technologies (NASDAQ:OSUR) and Cerus (NASDAQ:CERS) are both small-cap medical companies, but which is the better stock? We will contrast the two businesses based on the strength of their dividends, institutional ownership, valuation, media sentiment, earnings, analyst recommendations, profitability, risk and community ranking. Does the MarketBeat Community prefer OSUR or CERS? Cerus received 19 more outperform votes than OraSure Technologies when rated by MarketBeat users. Likewise, 72.30% of users gave Cerus an outperform vote while only 69.53% of users gave OraSure Technologies an outperform vote. CompanyUnderperformOutperformOraSure TechnologiesOutperform Votes55069.53% Underperform Votes24130.47% CerusOutperform Votes56972.30% Underperform Votes21827.70% Which has preferable valuation and earnings, OSUR or CERS? OraSure Technologies has higher revenue and earnings than Cerus. Cerus is trading at a lower price-to-earnings ratio than OraSure Technologies, indicating that it is currently the more affordable of the two stocks. CompanyGross RevenuePrice/Sales RatioNet IncomeEarnings Per SharePrice/Earnings RatioOraSure Technologies$224.26M1.29$53.65M$0.1525.87Cerus$156.37M2.13-$37.49M-$0.11-16.27 Is OSUR or CERS more profitable? OraSure Technologies has a net margin of 5.07% compared to Cerus' net margin of -11.19%. OraSure Technologies' return on equity of 3.55% beat Cerus' return on equity.Company Net Margins Return on Equity Return on Assets OraSure Technologies5.07% 3.55% 3.23% Cerus -11.19%-37.90%-10.35% Do institutionals & insiders believe in OSUR or CERS? 93.5% of OraSure Technologies shares are held by institutional investors. Comparatively, 78.4% of Cerus shares are held by institutional investors. 3.4% of OraSure Technologies shares are held by insiders. Comparatively, 3.4% of Cerus shares are held by insiders. Strong institutional ownership is an indication that endowments, large money managers and hedge funds believe a company is poised for long-term growth. Which has more risk & volatility, OSUR or CERS? OraSure Technologies has a beta of 0.05, suggesting that its share price is 95% less volatile than the S&P 500. Comparatively, Cerus has a beta of 1.2, suggesting that its share price is 20% more volatile than the S&P 500. Does the media refer more to OSUR or CERS? In the previous week, Cerus had 1 more articles in the media than OraSure Technologies. MarketBeat recorded 2 mentions for Cerus and 1 mentions for OraSure Technologies. Cerus' average media sentiment score of 1.91 beat OraSure Technologies' score of 0.44 indicating that Cerus is being referred to more favorably in the news media. Company Very Positive Positive Neutral Negative Very Negative Overall Sentiment OraSure Technologies 0 Very Positive mention(s) 0 Positive mention(s) 1 Neutral mention(s) 0 Negative mention(s) 0 Very Negative mention(s) Neutral Cerus 2 Very Positive mention(s) 0 Positive mention(s) 0 Neutral mention(s) 0 Negative mention(s) 0 Very Negative mention(s) Very Positive Do analysts prefer OSUR or CERS? OraSure Technologies currently has a consensus price target of $6.67, indicating a potential upside of 71.82%. Cerus has a consensus price target of $3.63, indicating a potential upside of 102.51%. Given Cerus' stronger consensus rating and higher possible upside, analysts plainly believe Cerus is more favorable than OraSure Technologies.Company Sell Ratings Hold Ratings Buy Ratings Strong Buy Ratings Rating Score OraSure Technologies 0 Sell rating(s) 2 Hold rating(s) 1 Buy rating(s) 0 Strong Buy rating(s) 2.33Cerus 0 Sell rating(s) 1 Hold rating(s) 3 Buy rating(s) 0 Strong Buy rating(s) 2.75 SummaryOraSure Technologies and Cerus tied by winning 9 of the 18 factors compared between the two stocks. Ad Paradigm Press[Urgent] Starlink Set For The Largest IPO In History?He turned PayPal from a tiny, off-the-radar startup… to a massive $64 billion giant. Then, he did it again with Tesla… which is up more than 19,500% since 2010. For perspective, that turns $100 invested into almost $20,000! And now, Elon could be set to do it for the third and final time… with what might be his biggest breakthrough yet. And for the first time ever, you have the rare chance to profit BEFORE the upcoming IPO.Click here now for the urgent details on this hidden play. Get Cerus News Delivered to You Automatically Sign up to receive the latest news and ratings for CERS and its competitors with MarketBeat's FREE daily newsletter. Email Address New MarketBeat Followers Over TimeWhat are MarkeBeat Followers?This chart shows the number of new MarketBeat users adding {thisCompany.Symbol} and its top 5 competitors to their watchlist. Each company is represented with a line over a 90 day period. Skip ChartMedia Sentiment Over TimeWhat is Media Sentiment?This chart shows the average media sentiment of NASDAQ and its competitors over the past 90 days as caculated by MarketBeat. The averaged score is equivalent to the following: Very Negative Sentiment <= -1.5, Negative Sentiment > -1.5 and <= -0.5, Neutral Sentiment > -0.5 and < 0.5, Positive Sentiment >= 0.5 and < 1.5, and Very Positive Sentiment >= 1.5.Skip Chart CERS vs. The Competition Export to ExcelMetricCerusSurgical & medical instruments IndustryMedical SectorNASDAQ ExchangeMarket Cap$332.42M$4.51B$5.38B$8.84BDividend YieldN/A36.80%5.13%4.09%P/E Ratio-16.2726.03105.1417.83Price / Sales2.1346.931,233.15158.41Price / CashN/A53.5740.4136.29Price / Book6.175.947.096.50Net Income-$37.49M$13.99M$119.65M$226.22M7 Day Performance4.07%3.27%2.25%4.03%1 Month Performance11.18%4.64%-2.33%4.92%1 Year Performance8.48%47.15%33.98%29.30% Cerus Competitors List Export to ExcelCompanyMarketRankShare PriceAnalysts' Price Target1Y Price PerformanceMarket CapRevenueP/E RatioEmployee CountIndicator(s)CERSCerus2.8305 of 5 stars$1.79+7.2%$3.63+102.5%+8.5%$332.42M$156.37M-16.27625Positive NewsOSUROraSure Technologies4.5154 of 5 stars$3.85+1.0%$6.67+73.2%-46.5%$287.17M$405.47M25.40638ANIKAnika Therapeutics3.6104 of 5 stars$17.43+1.5%$24.50+40.5%-17.5%$255.40M$166.66M-2.58357LUNGPulmonx2.9321 of 5 stars$6.42+3.5%$14.67+128.5%-35.9%$253.53M$68.68M-4.37250TCMDTactile Systems Technology3.8804 of 5 stars$15.89+2.1%$23.00+44.7%+32.6%$381.40M$274.42M23.77980UTMDUtah Medical Products3.47 of 5 stars$64.57+0.6%N/A-20.8%$218.89M$50.22M15.03180Positive NewsINOInovio Pharmaceuticals3.3938 of 5 stars$4.06+2.3%$38.00+836.0%-93.1%$105.97M$830,000.000.00127Analyst RevisionKIDSOrthoPediatrics4.0345 of 5 stars$26.46+3.8%$40.00+51.2%-17.1%$640.86M$148.73M-21.24200WSTWest Pharmaceutical Services4.9699 of 5 stars$320.28+2.8%$460.33+43.7%-9.8%$23.19B$2.95B47.5210,600COOCooper Companies3.6612 of 5 stars$99.96+0.9%$117.00+17.1%+18.9%$19.91B$3.59B55.6915,000Analyst DowngradeALGNAlign Technology4.7161 of 5 stars$228.39+2.0%$276.38+21.0%+4.0%$17.05B$3.86B38.9721,610News CoveragePositive News Related Companies and Tools Related Companies OSUR Competitors ANIK Competitors LUNG Competitors TCMD Competitors UTMD Competitors INO Competitors KIDS Competitors WST Competitors COO Competitors ALGN Competitors Top 10 Stock Comparisons Bank Stocks Artificial Intelligence Stocks Toy Stocks Growth Stocks Airline Stocks Chinese Stocks EV Charging Stocks Defense Stocks Lithium Stocks Pharmaceutical Stocks This page (NASDAQ:CERS) was last updated on 11/23/2024 by MarketBeat.com Staff From Our PartnersMissed Nvidia? Watch this ASAPThis little-known project that Bill Gates has been quietly working on that’s about to unleash an AI breakthrou...Brownstone Research | SponsoredThe Crypto That’s Making Wall Street SweatThe Crypto Wall Street Is Desperate to Hide It's happening now, right under everyone's radar. Big tech gian...Crypto 101 Media | SponsoredMusk’s new company could top a trillion?The investment legend who predicted the rise of Bitcoin, Facebook and streaming services like Netflix… Just...Paradigm Press | Sponsored24/7 Automated Profits in CryptoWhat if you could make consistent daily profits in crypto with minimal effort? Beyond trading lies a vast w...Crypto Swap Profits | Sponsored$2 Trillion Disappears Because of Fed's Secretive New Move$2 trillion has disappeared from the US government's books. The reason why is a new, secretive move being c...Stansberry Research | Sponsored“This Changes Everything” - Trump Hands Millions Massive IRS GiftNow it's your time to return the favor by taking advantage of this tax "revenge loophole." Because even as ...Colonial Metals | SponsoredUnveiled: NVIDIA’s "Secret Royalty" ProgramDid you know that there's an investment that will give you the opportunity to collect "royalties" every time N...Behind the Markets | SponsoredThe pin that pops the AI bubbleMy new documentary explores the background to this pattern and how and why I believe it will almost certainly ...Porter & Company | Sponsored Adding Choose a watchlist: Watchlist Adding You have already added five stocks to your watchlist. Upgrade to MarketBeat All Access to add more stocks to your watchlist. Adding Cerus Co. Please log in to your account or sign up in order to add this asset to your watchlist. Share Cerus With A Colleague Link copied to clipboard. Get 30 Days of MarketBeat All Access for Free Sign up for MarketBeat All Access to gain access to MarketBeat's full suite of research tools. Start Your 30-Day Trial MarketBeat All Access Features Best-in-Class Portfolio Monitoring Get personalized stock ideas. Compare portfolio to indices. Check stock news, ratings, SEC filings, and more. Stock Ideas and Recommendations See daily stock ideas from top analysts. Receive short-term trading ideas from MarketBeat. Identify trending stocks on social media. Advanced Stock Screeners and Research Tools Use our seven stock screeners to find suitable stocks. Stay informed with MarketBeat's real-time news. Export data to Excel for personal analysis. Sign in to your free account to enjoy these benefits In-depth profiles and analysis for 20,000 public companies. Real-time analyst ratings, insider transactions, earnings data, and more. Our daily ratings and market update email newsletter. Sign in to your free account to enjoy all that MarketBeat has to offer. Sign In Create Account Your Email Address: Email Address Required Your Password: Password Required Log In or Sign in with Facebook Sign in with Google Forgot your password? Your Email Address: Please enter your email address. Please enter a valid email address Choose a Password: Please enter your password. Your password must be at least 8 characters long and contain at least 1 number, 1 letter, and 1 special character. Create My Account (Free) or Sign in with Facebook Sign in with Google By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.
